Vontobel Holding Ltd. Purchases New Holdings in Oscar Health, Inc. $OSCR

Vontobel Holding Ltd. purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 17,004 shares of the company’s stock, valued at approximately $524,000.

Several other hedge funds have also recently added to or reduced their stakes in OSCR. TD Waterhouse Canada Inc. boosted its stake in Oscar Health by 16.7% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 13,350 shares of the company’s stock worth $399,000 after purchasing an additional 1,907 shares during the last quarter. North Capital Inc. purchased a new stake in shares of Oscar Health during the third quarter worth $319,000. Assenagon Asset Management S.A. grew its holdings in shares of Oscar Health by 107.5% during the third quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company’s stock worth $79,867,000 after buying an additional 1,341,716 shares in the last quarter. GK Wealth Management LLC purchased a new stake in shares of Oscar Health during the third quarter worth $100,000. Finally, GAMMA Investing LLC raised its position in shares of Oscar Health by 69.7% in the third quarter. GAMMA Investing LLC now owns 2,445 shares of the company’s stock valued at $75,000 after buying an additional 1,004 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. Piper Sandler reiterated an “overweight” rating and issued a $48.00 target price on shares of Oscar Health in a research report on Thursday, September 17th. Barclays boosted their price target on shares of Oscar Health from $39.00 to $49.00 and gave the stock an “overweight” rating in a research report on Thursday, September 17th. Weiss Ratings raised shares of Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Robert W. Baird upped their price objective on shares of Oscar Health from $27.00 to $33.00 and gave the company a “neutral” rating in a research note on Thursday, September 17th. Finally, UBS Group increased their price objective on shares of Oscar Health from $26.00 to $36.00 and gave the company a “neutral” rating in a report on Monday, October 12th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $34.90.

Oscar Health Stock Up 3.5%

Shares of OSCR opened at $33.68 on Wednesday. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $35.01. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The stock has a fifty day simple moving average of $31.69 and a two-hundred day simple moving average of $27.02. The company has a market capitalization of $10.39 billion, a PE ratio of 24.05, a price-to-earnings-growth ratio of 0.36 and a beta of 2.47.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.70. The firm had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company’s revenue was up 70.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.89) EPS. As a group, equities analysts forecast that Oscar Health, Inc. will post 1.83 EPS for the current year.

Insider Transactions at Oscar Health

In related news, Director Mario Schlosser sold 31,422 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $988,221.90. Following the completion of the sale, the director directly owned 449,444 shares in the company, valued at approximately $14,135,013.80. This trade represents a 6.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Vanessa Wittman sold 25,000 shares of Oscar Health stock in a transaction dated Friday, September 18th. The stock was sold at an average price of $32.24, for a total transaction of $806,000.00. Following the transaction, the director directly owned 112,121 shares in the company, valued at $3,614,781.04. This trade represents a 18.23% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 874,451 shares of company stock valued at $26,761,671 in the last three months. 22.64% of the stock is currently owned by corporate insiders.

About Oscar Health

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.